Factors Associated with Human Papillomavirus Vaccine Uptake Among Undergraduate Students in a Nigerian University: A Cross-Sectional Study
Preprint
Abstract
Background: Despite the proven effectiveness of human papillomavirus (HPV) vaccination in the prevention of HPV-related malignancies, vaccine uptake remains low in many low- and middle-income countries, including Nigeria. This study assessed the level of HPV vaccine uptake and associated factors among undergraduate students at a Nigerian university. Methods: A descriptive cross-sectional study was conducted among 410 undergraduates selected through a multi-stage sampling technique between July and September 2023. Data were collected using a structured, self-administered questionnaire and analysed with SPSS version 26. Results: Of the 410 male and female participants, 1.5% (6/410) received the HPV vaccine, all of whom were female (2.8% of the female respondents). Vaccine uptake was associated with knowing where to obtain the vaccine (p<0.001) and sex (p=0.037). Maternal levels of education, knowledge of the HPV vaccine, age, knowledge of HPV, and socioeconomic class were not related to vaccine uptake. Common reasons for non-uptake of the HPV vaccine included lack of awareness (63.2%; 211/334) and not knowing where to obtain the vaccine (19.2%; 64/334). Conclusion: The uptake of the HPV vaccine was very low, with a major barrier to vaccination being a lack of awareness about the vaccine. Contribution: This study provides a need to strengthened collaboration between university authorities and health authorities in raising awareness, improving accessibility, and enhancing the integration of HPV vaccination services within university settings in Nigeria.Keywords
This publication has 21 references indexed in Scilit:
- Human Papillomavirus Vaccination Coverage in Children Ages 9–17 Years: United States, 20222024
- Knowledge and acceptance of HPV vaccination and its associated factors among parents of daughters in Addis Ababa, Ethiopia: a community-based cross-sectional studyInfectious Agents and Cancer, 2021
- Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trialPapillomavirus Research, 2020
- Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case studyPLOS ONE, 2020
- Parental willingness to vaccinate adolescent daughters against human papilloma virus for cervical cancer prevention in western NigeriaPan African Medical Journal, 2020
- Status of HPV vaccine introduction and barriers to country uptakeVaccine, 2018
- Knowledge, practice and acceptability of HPV vaccine by mothers of adolescent girls in Ilorin, NigeriaSudan Journal of Medical Sciences, 2018
- Level and factors associated with uptake of Human papillomavirus infection vaccine among female adolescents in Lira District, UgandaPan African Medical Journal, 2018
- The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic ReviewJournal of Primary Care & Community Health, 2017
- Infecção pelo papilomavírus humano: etiopatogenia, biologia molecular e manifestações clínicasAnais Brasileiros de Dermatologia, 2011